JUL 21, 2020 11:07 PM PDT

FDA Produces Draft Guidelines on Developing Cannabis Drugs

WRITTEN BY: Angela Dowden

The FDA’s Center for Drug Evaluation and Research has produced guidelines for research into cannabis-related ingredients that may make potential drugs.

The document covers the drug review and approval process, including clinical trials, that must be followed by research teams working with cannabis compounds. Botanical raw materials, extracts and highly purified substances of botanical origin are included within the scope of the new guidelines. However fully synthetic versions of substances that occur in cannabis are not included, as these are already regulated the same as other fully synthetic drugs.  

The guidelines also lay out the approved sources of cannabis that investigators are allowed to use. For cannabis containing more than 0.3 percent of the psychoactive ingredient THC, the FDA confirm that this must be sourced from the National Institute on Drug Abuse’s (NIDA) Drug Supply Program (DSP), which is still the only domestic federally legal source. However the 2018 Farm Bill legalized hemp plants containing less than 0.3 percent THC, so researchers can now access hemp that meet this specification from any manufacturer.

Though the new guidelines offer useful clarity for researchers investigating cannabis compounds as drug candidates, they are still notable for their absence of any guidance on CBD oil. Already a big sales ticket item across the US, CBD exists in some sort of semi-legal limbo land.

While the Farm Bill legalized hemp, it did not legalize CBD, moving its enforcement from the Drug Enforcement Administration to the FDA. When the FDA approved the epilepsy drug Epidiolex, which contains CBD, it subsequently told companies that they cannot not add the ingredient to food or drink or make health claims for its use in topicals.

The FDA is currently in an open-ended consultation period over CBD that should result in the agency finally issuing regulations for its legal marketing.

“There are many questions to explore regarding the science, safety, effectiveness and quality of products containing CBD, and we need to do our due diligence,” an FDA spokesperson told website MarketWatch in written comments.

The FDA has issued warnings in situations where companies marketing CBD as supplements made unauthorized claims about cancer, arthritis and other diseases.

 Sources: MarketWatch, FDA, Marijuana Moment

 

About the Author
  • I'm a Journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
AUG 21, 2020
Cancer
Investigating Cancer's Metabolism for a New Drug Target
AUG 21, 2020
Investigating Cancer's Metabolism for a New Drug Target
Cancer cells are quite similar to normal cells in many ways, but it’s the small differences that really matter. On ...
AUG 20, 2020
Plants & Animals
Honoring World Mosquito Day
AUG 20, 2020
Honoring World Mosquito Day
August 20th, 2020 is World Mosquito Day. Why celebrate an animal dubbed as one of the “world’s deadliest&rdq ...
SEP 01, 2020
Clinical & Molecular DX
Scalp Implants Monitor Epileptic Seizures
SEP 01, 2020
Scalp Implants Monitor Epileptic Seizures
Neuroscientists have developed devices that, when implanted under the scalp of individuals living with epilepsy, can mon ...
SEP 03, 2020
Clinical & Molecular DX
Tiny Diagnostic Robot Tank Explores the Colon
SEP 03, 2020
Tiny Diagnostic Robot Tank Explores the Colon
The colon, also known as the large intestine, is where the final stages of digestion happen. Here, water, salts, and rem ...
SEP 14, 2020
Genetics & Genomics
Why Defects in One Gene Can Lead to Cancer in Kids
SEP 14, 2020
Why Defects in One Gene Can Lead to Cancer in Kids
While they may occur in adults, a rare, aggressive type of brain cancer called atypical teratoid rhabdoid tumors tend to ...
SEP 16, 2020
Cardiology
Stem Cells Can Generate a 3D Mini-Model of the Heart
SEP 16, 2020
Stem Cells Can Generate a 3D Mini-Model of the Heart
The heart is a special organ, and while we know a lot about how it develops, there are still mysteries.
Loading Comments...